Case Report A rare Demyelinating Disease: cause of acute hemiparesis in a young male
DOI:
https://doi.org/10.15713/ins.bhj.84Keywords:
Tumefactive Demyelinating Disease, Magnetic Resource Imaging, Multiple Sclerosis, Plasma ExchangeAbstract
Demyelinating diseases of the central nervous system are frequently encountered pathological entities; Multiple Sclerosis (MS) being the most common. Atypical forms of demyelinating diseases such as tumefactive demyelination run an aggressive course, masquerading MS but without classical features of MS. These aggressive entities represent a diagnostic and therapeutic challenge for physicians. The manifestations of a demyelinating disease are protean. This case was fascinating for two reasons: the diagnostic challenge it posed in the face of different etiologies of a demyelinating disease and the rapid response to plasma exchange and rituximab therapy in the acute phase of the disease.
References
T. A. Hardy and J. Chataway, “Tumefactive demyelination: An approach to diagnosis and management,” Journal of Neurology, Neurosurgery & Psychiatry.2013; 84(9): 1047–1053.
Lucchinetti CF, Gavrilova RH, Metz I, et al.: Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008; 131:1759-75.
S. Poser, W. Lüer, H. Bruhn, J. Frahm, Y. Brück, and K. Felgenhauer, “Acute demyelinating disease. Classification and non-invasive diagnosis,” Acta Neurologica Scandinavica.1992; 86(6) 579–585.
C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria,” Annals of Neurology. 2011; 69(2):292–302.
H. S. Malhotra, K. K. Jain, A. Agarwal et al., “Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy,” Multiple Sclerosis Journal. 2009:15(2). 193–203.
Hu W, Lucchinetti CF. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol. 2009; 31:439–53.
Algahtani H, Shirah B, Alassiri A: Tumefactive demyelinating lesions: a comprehensive review. Mult Scler Relat Disord. 2017, 14:72-79
R. Conforti, R. Capasso, R. Galasso, M. Cirillo, G. Taglialatela, and L. Galasso, “A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: Doubtful CT, MRI, and bioptic findings Case report and literature review,” Medicine (United States), vol. 95, no. 36, 2016.
Capello E, Mancardi GL. Marburg type and Balò's concentric sclerosis: Rare and acute variants of multiple sclerosis. Neurol Sci 2004;25(Suppl 4):S361-3.
Stadelmann C, Brück W. Lessons from the neuropathology of atypical forms of multiple sclerosis. Neurol Sci 2004;25(Suppl 4): S319-22
Kesselring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D, et al. Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 1990; 113:291-302.
De Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, et al. Acute fulminant demyelinating disease: A descriptive study of 60 patients. Arch Neurol 2007; 64:1426-32.
K. M. Ikeda, D. H. Lee, J. A. Fraser, S. Mirsattari, and S. A. Morrow, “Plasma exchange in a patient with tumefactive, corticosteroid-resistant multiple sclerosis,” International Journal of MS Care. 2015; 17(5): pp. 231–235.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bombay Hospital Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
